CONMED Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Patrick J. Beyer
- Full Time Employees
- 3,900
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 11311 Concept Boulevard Largo FL United States of America 33773-4908
- IPO Date
- Jul 23, 1987
- CIK
- 0000816956
- Website
- conmed.com
- Similar Companies
- Business
- CONMED Corporation (NYSE: CNMD) develops, manufactures, and markets surgical devices and supplies for use in minimally invasive procedures and orthopedics worldwide. The company offers a broad portfolio of products including powered instruments such as the Buffalo Filter and HiClear Oscillating Saw; orthopedic implants and biologics under brands like BioBrace and CrossFix; endoscopy devices including the DuraClip and OneSnip; general surgery instruments like the Repose Retractor System; and patient positioners such as the Plastech Gel products. CONMED operates through two primary segments—Orthopedic Surgery and General Surgery—serving hospitals, ambulatory surgery centers, and outpatient clinics primarily in the United States, Europe, and Asia-Pacific. Founded in 1970 and headquartered in Largo, Florida, the company maintains manufacturing facilities in the U.S., Mexico, and Poland. In recent developments, CONMED completed the acquisition of In2Bones Global, Inc. in March 2024, expanding its upper extremity orthopedic portfolio with innovative implants and instrumentation; launched the next-generation AirSeal iGS system in 2024 to enhance laparoscopic procedures; and reported strong revenue growth in its orthopedic segment during 2025, driven by strategic investments in sports medicine and trauma solutions.[web:previous]
Arrowstreet Capital Limited Partnership Purchases 287,150 Shares of CONMED Corporation $CNMD
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
CONMED Q2 Earnings Call Highlights
Conmed (CNMD) Reports Q2 Earnings: What Key Metrics Have to Say
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula
Bessemer Group Inc. Purchases 36,940 Shares of CONMED Corporation $CNMD
Allspring Global Investments Holdings LLC Increases Holdings in CONMED Corporation $CNMD
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors